$0.40
Value $22M
Health In TechvsMorgan Stanley
HIT and MS stock compared: price, dividend, valuation and results, from SEC filings.
-25.98%
$190.65
Value $303B
Health In Tech (HIT) has a market value of $22M and Morgan Stanley (MS) $303B. Over the last year, with dividends, HIT moved -78.4% and MS +14.7%. Dividend yield: HIT none, MS 2.26%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HIT$22M
MS$303B
MS is 13,707 times HIT
Revenue, 12 months
HIT$31M
MS$80.2B
MS is 2,592 times HIT
Net income, 12 months
HIT-$11M
MS$20.5B
Operating margin
HIT–
MS–
ROIC
HIT-67.4%
MS4.4%
71.8 points apart
P/E
HIT–
MS15.3
Dividend yield
HIT0.0%
MS2.3%
2.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HIT-78.4%
MS+14.7%
| Period | HITWith dividends | MSWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -78.4%Price -78.4% | +14.7%Price +12.2% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
HITHealth In TechMSMorgan Stanley
Valuation
HITMS| Price | $0.40 | $190.65 |
|---|---|---|
| Market value | $22M | $303B |
| Enterprise value (EV) | $19M | – |
| P/E | – | 15.3 |
| P/E, 5-year median | – | 15.8 |
| P/B | 1.7 | 2.6 |
| EV/EBIT | – | – |
| Free cash flow yield | – | – |
Results and growth
HITMS| Revenue, 12 months | $31M | $80.2B |
|---|---|---|
| Net income, 12 months | -$11M | $20.5B |
| Free cash flow, 12 months | – | – |
| Earnings per share, 12 months | -$0.19 | $12.60 |
| Revenue growth, year on year | 71.0% | 14.4% |
| Revenue growth a year, past | +31.9%over 2 years | +7.7%over 5 years |
| EPS growth a year, past | +100.0%over 1 years | +9.6%over 5 years |
Margins and returns on capital
HITMS| Gross margin | 50.5% | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | -37.1% | 25.5% |
| ROIC | -67.4% | 4.4% |
| ROE | -64.9% | 18.0% |
Balance sheet
HITMS| Cash | $10M | $244B |
|---|---|---|
| Total debt | $6.7M | $378B |
| Net debt / EBITDA | – | – |
| Interest cover | – | – |
Dividends and buybacks
HITMS| Dividend yield | – | 2.3% |
|---|---|---|
| Dividend per share, 12 months | – | $4.30 |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 1.5% |
| Shareholder yield | – | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Health In Tech or Morgan Stanley?
By market value, Morgan Stanley ($303B) is about 13,706.5 times Health In Tech ($22M), at today's prices.
How did HIT and MS stock do over the last 1 years?
Since November 12, 2025, HIT's price moved -78.4% and MS's +12.2%. With dividends: HIT -78.4% (-78.4% a year), MS +14.7% (+14.7% a year). Past returns do not predict future ones.
Which pays the higher dividend, HIT or MS?
The dividend yield at today's price is none for Health In Tech and 2.26% for Morgan Stanley. Over the last twelve months they paid – and $4.30 per share.
Which has the higher profit margins, Health In Tech or Morgan Stanley?
Over the last twelve months, the net margin was -37.1% for Health In Tech and 25.5% for Morgan Stanley, and the operating margin – and –. Revenue was $31M and $80.2B.
Which is the better investment, Health In Tech or Morgan Stanley?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.